PERI-PROCEDURAL MYOCARDIAL INFARCTION WAS SIGNIFICANTLY REDUCED WITH PITAVASTATIN 4 MG WHEN COMPARED TO PITAVASTATIN 1MG
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, S. J. | - |
dc.contributor.author | Lim, D. S. | - |
dc.date.accessioned | 2021-09-01T11:02:24Z | - |
dc.date.available | 2021-09-01T11:02:24Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-08 | - |
dc.identifier.issn | 0021-9150 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/64041 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.title | PERI-PROCEDURAL MYOCARDIAL INFARCTION WAS SIGNIFICANTLY REDUCED WITH PITAVASTATIN 4 MG WHEN COMPARED TO PITAVASTATIN 1MG | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lim, D. S. | - |
dc.identifier.doi | 10.1016/j.atherosclerosis.2019.06.106 | - |
dc.identifier.wosid | 000482110800105 | - |
dc.identifier.bibliographicCitation | ATHEROSCLEROSIS, v.287, pp.E36 - E36 | - |
dc.relation.isPartOf | ATHEROSCLEROSIS | - |
dc.citation.title | ATHEROSCLEROSIS | - |
dc.citation.volume | 287 | - |
dc.citation.startPage | E36 | - |
dc.citation.endPage | E36 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.